Drug interactions
Daunorubicin + Encorafenib
Severity: Moderate
Daunorubicin and Encorafenib: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Encorafenib may inhibit efflux transporters such as BCRP, potentially increasing exposure to substrates. Higher daunorubicin levels could worsen myelosuppression and cardiotoxicity, although the clinical size of the effect is uncertain.
What this interaction means in plain words
Daunorubicin and Encorafenib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Daunorubicin belongs to Oncology; Encorafenib belongs to Oncology.
Why it happens
Encorafenib inhibition of BCRP efflux transport may increase daunorubicin exposure.
What to do
Monitor blood counts and cardiac function closely; consider daunorubicin dose reduction if toxicity emerges.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Daunorubicin and Encorafenib, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Daunorubicin
- Adenovirus types 4 and 7 live + Daunorubicin Contraindicated
- Belatacept + Daunorubicin Major
- Cyclosporine + Daunorubicin Major
- Cyclosporin + Daunorubicin Major
- Daunorubicin + Dengue vaccine Major
- Daunorubicin + Etrasimod Major
Other interactions of Encorafenib
Frequently asked questions
Can I take Daunorubicin with Encorafenib?
MediHelp rates the interaction as moderate. Daunorubicin and Encorafenib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Encorafenib may inhibit efflux transporters such as BCRP, potentially increasing exposure to substrates. Higher daunorubicin levels could worsen myelosuppression and cardiotoxicity, although the clinical size of the effect is uncertain.
How serious is the interaction between Daunorubicin and Encorafenib?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and cardiac function closely; consider daunorubicin dose reduction if toxicity emerges.
What other medicines interact with Daunorubicin?
MediHelp also lists interactions of Daunorubicin with, for example, Adenovirus types 4 and 7 live, Belatacept, Cyclosporine. The full list is on the Daunorubicin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
